In order to investigate the molecular expression pattern of TRIM56, we evaluated the expression levels of TRIM56 in IDH wild-type (WT) and IDH mutant (Mut) gliomas and in 1p/19q co-deletion and without 1p/19q co-deletion. Here, IDH2 is linked to central nervous system cancer.